Treatment-emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series.

Samuel DeKovenMark NaccaratoChanson J BrummeDarrell Hoi-San Tan

Published in: HIV medicine (2023)

Despite a generally high genetic barrier to resistance, NRTI resistance-associated mutations may emerge during therapy with BIC/TAF/FTC in the setting of suboptimal adherence.

Keyphrases

antiretroviral therapy
hiv infected
human immunodeficiency virus
hiv aids
stem cells
hiv positive
gene expression
skeletal muscle
adipose tissue
copy number
weight loss
smoking cessation